-DOCSTART- (S016816561300552X)

The	0,3	O	B-Process
transfer	4,12	O	I-Process
of	13,15	O	O
a	16,17	O	B-Process
laboratory	18,28	O	I-Process
process	29,36	O	I-Process
into	37,41	O	O
a	42,43	O	B-Material
manufacturing	44,57	O	I-Material
facility	58,66	O	I-Material
is	67,69	O	O
one	70,73	O	O
of	74,76	O	O
the	77,80	O	O
most	81,85	O	O
critical	86,94	O	O
steps	95,100	O	O
required	101,109	O	O
for	110,113	O	O
the	114,117	O	B-Process
large	118,123	O	I-Process
scale	124,129	O	I-Process
production	130,140	O	I-Process
of	141,143	O	O
cell	144,148	O	B-Material
-	148,149	O	I-Material
based	149,154	O	I-Material
therapy	155,162	O	I-Material
products	163,171	O	I-Material
.	171,172	O	O

This	173,177	O	O
study	178,183	O	O
describes	184,193	O	O
the	194,197	O	B-Method
first	198,203	O	I-Method
published	204,213	O	I-Method
protocol	214,222	O	I-Method
for	223,226	O	O
scalable	227,235	O	B-Process
automated	236,245	O	I-Process
expansion	246,255	O	I-Process
of	256,258	O	O
human	259,264	O	B-Material
induced	265,272	O	I-Material
pluripotent	273,284	O	I-Material
stem	285,289	O	I-Material
cell	290,294	O	I-Material
lines	295,300	O	I-Material
growing	301,308	O	B-Process
in	309,311	O	O
aggregates	312,322	O	B-Material
in	323,325	O	O
feeder	326,332	O	B-Material
-	332,333	O	I-Material
free	333,337	O	I-Material
and	338,341	O	I-Material
chemically	342,352	O	I-Material
defined	353,360	O	I-Material
medium	361,367	O	I-Material
.	367,368	O	O

Cells	369,374	O	B-Material
were	375,379	O	O
successfully	380,392	O	O
transferred	393,404	O	B-Process
between	405,412	O	O
different	413,422	O	B-Material
sites	423,428	O	I-Material
representative	429,443	O	O
of	444,446	O	O
research	447,455	O	B-Data
and	456,459	O	I-Data
manufacturing	460,473	O	I-Data
settings	474,482	O	I-Data
;	482,483	O	O
and	484,487	O	O
passaged	488,496	O	B-Process
manually	497,505	O	I-Process
and	506,509	O	O
using	510,515	O	O
the	516,519	O	B-Material
CompacT	520,527	O	I-Material
SelecT	528,534	O	I-Material
automation	535,545	O	I-Material
platform	546,554	O	I-Material
.	554,555	O	O

Modified	556,564	O	B-Process
protocols	565,574	O	I-Process
were	575,579	O	O
developed	580,589	O	O
for	590,593	O	O
the	594,597	O	B-Material
automated	598,607	O	I-Material
system	608,614	O	I-Material
and	615,618	O	O
the	619,622	O	B-Process
management	623,633	O	I-Process
of	634,636	O	O
cells	637,642	O	B-Material
aggregates	643,653	O	I-Material
(	654,655	O	I-Material
clumps	655,661	O	I-Material
)	661,662	O	I-Material
was	663,666	O	O
identified	667,677	O	O
as	678,680	O	O
the	681,684	O	O
critical	685,693	O	O
step	694,698	O	O
.	698,699	O	O

Cellular	700,708	O	B-Data
morphology	709,719	O	I-Data
,	719,720	O	O
pluripotency	721,733	O	B-Process
gene	734,738	O	I-Process
expression	739,749	O	I-Process
and	750,753	O	O
differentiation	754,769	O	B-Process
into	770,774	O	O
the	775,778	O	B-Material
three	779,784	O	I-Material
germ	785,789	O	I-Material
layers	790,796	O	I-Material
have	797,801	O	O
been	802,806	O	O
used	807,811	O	O
compare	812,819	O	B-Process
the	820,823	O	B-Data
outcomes	824,832	O	I-Data
of	833,835	O	O
manual	836,842	O	B-Process
and	843,846	O	I-Process
automated	847,856	O	I-Process
processes	857,866	O	I-Process
.	866,867	O	O

-DOCSTART- (S2213671113001306)

Transplantation	0,15	O	B-Process
of	16,18	O	O
the	19,22	O	B-Material
retinal	23,30	O	I-Material
pigment	31,38	O	I-Material
epithelium	39,49	O	I-Material
(	50,51	O	I-Material
RPE	51,54	O	I-Material
)	54,55	O	I-Material
is	56,58	O	O
being	59,64	O	O
developed	65,74	O	O
as	75,77	O	O
a	78,79	O	B-Process
cell	80,84	O	I-Process
-	84,85	O	I-Process
replacement	85,96	O	I-Process
therapy	97,104	O	I-Process
for	105,108	O	O
age	109,112	O	B-Process
-	112,113	O	I-Process
related	113,120	O	I-Process
macular	121,128	O	I-Process
degeneration	129,141	O	I-Process
.	141,142	O	O

Human	143,148	O	B-Material
embryonic	149,158	O	I-Material
stem	159,163	O	I-Material
cell	164,168	O	I-Material
(	169,170	O	I-Material
hESC	170,174	O	I-Material
)	174,175	O	I-Material
and	176,179	O	O
induced	180,187	O	B-Process
pluripotent	188,199	O	B-Material
stem	200,204	O	I-Material
cell	205,209	O	I-Material

(	210,211	O	I-Material
iPSC)-derived	211,224	O	I-Material
RPE	225,228	O	I-Material
are	229,232	O	O
currently	233,242	O	O
translating	243,254	O	B-Process
toward	255,261	O	O
clinic	262,268	O	B-Material
.	268,269	O	O

We	270,272	O	O
introduce	273,282	O	O
the	283,286	O	B-Material
adult	287,292	O	I-Material
human	293,298	O	I-Material
RPE	299,302	O	I-Material
stem	303,307	O	I-Material
cell	308,312	O	I-Material
(	313,314	O	I-Material
hRPESC	314,320	O	I-Material
)	320,321	O	I-Material
as	322,324	O	O
an	325,327	O	B-Material
alternative	328,339	O	I-Material
RPE	340,343	O	I-Material
source	344,350	O	I-Material
.	350,351	O	O

Polarized	352,361	O	B-Material
monolayers	362,372	O	I-Material
of	373,375	O	O
adult	376,381	O	B-Material
hRPESC	382,388	O	I-Material
-	388,389	O	I-Material
derived	389,396	O	I-Material
RPE	397,400	O	I-Material
grown	401,406	O	B-Process
on	407,409	O	O
polyester	410,419	O	B-Material

(	420,421	O	I-Material
PET	421,424	O	I-Material
)	424,425	O	I-Material
membranes	426,435	O	I-Material
had	436,439	O	O
near	440,444	O	B-Data
-	444,445	O	I-Data
native	445,451	O	I-Data
characteristics	452,467	O	I-Data
.	467,468	O	O

Trephined	469,478	O	B-Material
pieces	479,485	O	I-Material
of	486,488	O	I-Material
RPE	489,492	O	I-Material
monolayers	493,503	O	I-Material
on	504,506	O	O
PET	507,510	O	B-Material
were	511,515	O	O
transplanted	516,528	O	B-Process
subretinally	529,541	O	I-Process
in	542,544	O	O
the	545,548	O	B-Material
rabbit	549,555	O	I-Material
,	555,556	O	I-Material
a	557,558	O	I-Material
large	559,564	O	I-Material
-	564,565	O	I-Material
eyed	565,569	O	I-Material
animal	570,576	O	I-Material
model	577,582	O	I-Material
.	582,583	O	O

After	584,589	O	O
4	590,591	O	O
days	592,596	O	O
,	596,597	O	O
retinal	598,605	O	B-Material
edema	606,611	O	I-Material
was	612,615	O	O
observed	616,624	O	O
above	625,630	O	O
the	631,634	O	B-Material
implant	635,642	O	I-Material
,	642,643	O	O
detected	644,652	O	B-Process
by	653,655	O	O
spectral	656,664	O	B-Method
domain	665,671	O	I-Method
optical	672,679	O	I-Method
coherence	680,689	O	I-Method
tomography	690,700	O	I-Method
(	701,702	O	I-Method
SD	702,704	O	I-Method
-	704,705	O	I-Method
OCT	705,708	O	I-Method
)	708,709	O	I-Method
and	710,713	O	I-Method
fundoscopy	714,724	O	I-Method
.	724,725	O	O

At	726,728	O	O
1	729,730	O	O
week	731,735	O	O
,	735,736	O	O
retinal	737,744	O	B-Process
atrophy	745,752	O	I-Process
overlying	753,762	O	O
the	763,766	O	B-Material
fetal	767,772	O	I-Material
or	773,775	O	I-Material
adult	776,781	O	I-Material
transplant	782,792	O	I-Material
was	793,796	O	O
observed	797,805	O	O
,	805,806	O	O
remaining	807,816	O	O
stable	817,823	O	B-Data
thereafter	824,834	O	O
.	834,835	O	O

Histology	836,845	O	B-Process
obtained	846,854	O	O
4	855,856	O	O
weeks	857,862	O	O
after	863,868	O	O
implantation	869,881	O	B-Process
confirmed	882,891	O	O
a	892,893	O	B-Material
continuous	894,904	O	I-Material
polarized	905,914	O	I-Material
human	915,920	O	I-Material
RPE	921,924	O	I-Material
monolayer	925,934	O	I-Material
on	935,937	O	O
PET	938,941	O	B-Material
.	941,942	O	O

Taken	943,948	O	O
together	949,957	O	O
,	957,958	O	O
the	959,962	O	B-Material
xeno	963,967	O	I-Material
-	967,968	O	I-Material
RPE	968,971	O	I-Material
survived	972,980	O	O
with	981,985	O	O
retained	986,994	O	B-Data
characteristics	995,1010	O	I-Data
in	1011,1013	O	O
the	1014,1017	O	B-Material
subretinal	1018,1028	O	I-Material
space	1029,1034	O	I-Material
.	1034,1035	O	O

These	1036,1041	O	O
experiments	1042,1053	O	O
support	1054,1061	O	O
that	1062,1066	O	O
adult	1067,1072	O	B-Material
hRPESC	1073,1079	O	I-Material
-	1079,1080	O	I-Material
derived	1080,1087	O	I-Material
RPE	1088,1091	O	I-Material
are	1092,1095	O	O
a	1096,1097	O	O
potential	1098,1107	O	O
source	1108,1114	O	O
for	1115,1118	O	O
transplantation	1119,1134	O	B-Process
therapies	1135,1144	O	I-Process
.	1144,1145	O	O

Graphical	1146,1155	O	O
Abstract	1156,1164	O	O
Highlights	1165,1175	O	O
•	1176,1177	O	O
Adult	1178,1183	O	B-Material
hRPESC	1184,1190	O	I-Material
-	1190,1191	O	I-Material
derived	1191,1198	O	I-Material
RPE	1199,1202	O	I-Material
had	1203,1206	O	O
comparable	1207,1217	O	O
in	1218,1220	O	B-Method
vitro	1221,1226	O	I-Method
characteristics	1227,1242	O	B-Data
to	1243,1245	O	O
fetal	1246,1251	O	B-Material
hRPE	1252,1256	O	I-Material
•	1257,1258	O	O

hRPE	1259,1263	O	B-Material
monolayers	1264,1274	O	I-Material
survived	1275,1283	O	O
4	1284,1285	O	O
weeks	1286,1291	O	O
on	1292,1294	O	O
PET	1295,1298	O	B-Material
carriers	1299,1307	O	I-Material
under	1308,1313	O	O
the	1314,1317	O	B-Material
rabbit	1318,1324	O	I-Material
retina	1325,1331	O	I-Material
•	1332,1333	O	O

Better	1334,1340	O	O
xenograft	1341,1350	O	B-Process
survival	1351,1359	O	I-Process
may	1360,1363	O	O
be	1364,1366	O	O
due	1367,1370	O	O
to	1371,1373	O	O
the	1374,1377	O	B-Data
maintained	1378,1388	O	I-Data
hRPE	1389,1393	O	I-Data
cell	1394,1398	O	I-Data
polarity	1399,1407	O	I-Data

•	1408,1409	O	O
Atrophy	1410,1417	O	B-Process
of	1418,1420	O	O
the	1421,1424	O	B-Material
retina	1425,1431	O	I-Material
overlaying	1432,1442	O	B-Process
the	1443,1446	O	B-Material
hRPE	1447,1451	O	I-Material
xenograft	1452,1461	O	I-Material
remains	1462,1469	O	O
a	1470,1471	O	O
future	1472,1478	O	O
challenge	1479,1488	O	O
Stanzel	1489,1496	O	O
et	1497,1499	O	O
al	1500,1502	O	O
.	1502,1503	O	O

have	1504,1508	O	O
transplanted	1509,1521	O	B-Process
polarized	1522,1531	O	B-Material
monolayers	1532,1542	O	I-Material
of	1543,1545	O	O
human	1546,1551	O	B-Material
retinal	1552,1559	O	I-Material
pigment	1560,1567	O	I-Material
epithelium	1568,1578	O	I-Material
(	1579,1580	O	I-Material
hRPE	1580,1584	O	I-Material
)	1584,1585	O	I-Material
grown	1586,1591	O	B-Process
on	1592,1594	O	O
polyester	1595,1604	O	B-Material
membranes	1605,1614	O	I-Material
derived	1615,1622	O	B-Process
from	1623,1627	O	O
adult	1628,1633	O	B-Material
hRPE	1634,1638	O	I-Material
stem	1639,1643	O	I-Material
cells	1644,1649	O	I-Material
or	1650,1652	O	I-Material
fetal	1653,1658	O	I-Material
tissue	1659,1665	O	I-Material
under	1666,1671	O	O
the	1672,1675	O	B-Material
rabbit	1676,1682	O	I-Material
retina	1683,1689	O	I-Material
.	1689,1690	O	O

The	1691,1694	O	B-Material
xeno	1695,1699	O	I-Material
-	1699,1700	O	I-Material
RPE	1700,1703	O	I-Material
survived	1704,1712	O	O
4	1713,1714	O	O
weeks	1715,1720	O	O
with	1721,1725	O	O
retained	1726,1734	O	O
cell	1735,1739	O	B-Data
polarity	1740,1748	O	I-Data
characteristics	1749,1764	O	I-Data
in	1765,1767	O	O
the	1768,1771	O	B-Material
subretinal	1772,1782	O	I-Material
space	1783,1788	O	I-Material
.	1788,1789	O	O

These	1790,1795	O	O
experiments	1796,1807	O	O
support	1808,1815	O	O
that	1816,1820	O	O
adult	1821,1826	O	B-Material
hRPESC	1827,1833	O	I-Material
-	1833,1834	O	I-Material
derived	1834,1841	O	I-Material
RPE	1842,1845	O	I-Material
are	1846,1849	O	O
a	1850,1851	O	O
potential	1852,1861	O	O
source	1862,1868	O	O
for	1869,1872	O	O
transplantation	1873,1888	O	B-Process
therapies	1889,1898	O	I-Process
.	1898,1899	O	O

